Flagship Pioneering Inc.'s Net Worth

$4.81 Billion

Estimate Recalculated Feb 29, 2024 04:46PM EST

Who is Flagship Pioneering Inc.?

Flagship Pioneering Inc. has an estimated net worth of $4.81 Billion. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Moderna, Inc., Kaleido Biosciences, Inc., BG Medicine, Inc., Omega Therapeutics, Inc., Seres Therapeutics, Inc., Foghorn Therapeutics Inc., Codiak BioSciences, Inc., Sigilon Therapeutics, Inc., Evelo Biosciences, Inc., Axcella Health Inc., HELICOS BIOSCIENCES CORP, and ACCELERON PHARMA INC.

SEC CIK

Flagship Pioneering Inc.'s CIK is 0001400240

Past Insider Trading and Trends

2011 was Flagship Pioneering Inc.'s most active year for acquiring shares with 26 total transactions. Flagship Pioneering Inc.'s most active month to acquire stocks was the month of November. 2014 was Flagship Pioneering Inc.'s most active year for disposing of shares, totalling 40 transactions. Flagship Pioneering Inc.'s most active month to dispose stocks was the month of November. 2022 saw Flagship Pioneering Inc. paying a total of $67,525,463.59 for 36,135,502 shares, this is the most they've acquired in one year. In 2023 Flagship Pioneering Inc. cashed out on 12,578,995 shares for a total of $11,901,982.40, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sana Biotechnology, Inc. (SANA) Snapshot price: $6.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Feb 12
Form 4
-32.03%
-11.78M
25M
Sep 13
Form 4
34.24M
34.24M
Feb 8
Form 3
0
0
No matching records found

Moderna, Inc. (MRNA) Snapshot price: $99.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
47.34M
47.34M
Dec 11
Form 3
0
0
No matching records found

Kaleido Biosciences, Inc. (KLDO) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.12%
12M
$15.00
$13,999,995.00
37.48M
Mar 4
Form 3
0
0
No matching records found

BG Medicine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.33%
4.48K
$1.21
-$16.34
58.23K
Jul 27
Form 4
+10.40%
74.11K
$1.21
-$232.42
786.97K
Jul 27
Form 4
0
0
Jul 14
Form 4
-92.41%
-2.26M
$0.24
$174.72
185.75K
Dec 3 - Dec 4
Form 4
-100.00%
-640.37K
$0.24
$198.60
0
Dec 3 - Dec 4
Form 4
-100.00%
-92.29K
$0.24
$21.10
0
Dec 3 - Dec 4
Form 4
-100.00%
-92.13K
$0.24
$20.72
0
Dec 3 - Dec 4
Form 4
+33.80%
2M
$2.00
$4,000,000.00
7.92M
Jan 30
Form 4
-100.00%
-276.60K
$2.93
-$22.15
0
Aug 20 - Aug 21
Form 4
-100.00%
-104.93K
$1.99
-$10.38
0
May 21 - May 23
Form 4
-64.80%
-193.13K
104.93K
Sep 19
Form 4
+233.07%
4.73M
$7.00
$6,084,547.00
6.76M
Sep 27 - Feb 9
Form 3
0
0
No matching records found

Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.595

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+60.26%
3.32M
$5.78
$19,208,731.80
8.84M
Feb 27
Form 4
23.71M
$17.00
23.71M
Aug 3
Form 4
23.71M
$17.00
23.71M
Aug 3
Form 3
0
0
Form 3
0
0
No matching records found